Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2002-11-22
2009-02-03
Horlick, Kenneth R. (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200
Reexamination Certificate
active
07485417
ABSTRACT:
This invention provides novel processes for amplifying nucleic acid sequences of interest, including linear and non-linear amplification. In linear amplification, a single initial primer or nucleic acid construct is utilized to carry out the amplification process. In non-linear amplification, a first initial primer or nucleic acid construct is employed with a subsequent initial primer or nucleic acid construct. In other non-linear amplification processes provided by this invention, a first initial primer or nucleic acid construct is deployed with a second initial primer or nucleic acid construct to amplify the specific nucleic acid sequence of interest and its complement that are provided. A singular primer or a singular nucleic acid construct capable of non-linear amplification can also be used to carry out non-linear amplification in accordance with this invention. Post-termination labeling process for nucleic acid sequencing is also disclosed in this invention that is based upon the detection of tagged molecules that are covalently bound to chemically reactive groups provided for chain terminators. A process for producing nucleic acid sequences having decreased thermodynamic stability to complementary sequences is also provided and achieved by this invention. Unique nucleic acid polymers are also disclosed and provided in addition to other novel compositions, kits and the like.
REFERENCES:
patent: 4707440 (1987-11-01), Stavrianopoulos
patent: 4729947 (1988-03-01), Middendorf et al.
patent: 4749647 (1988-06-01), Thomas et al.
patent: 5027880 (1991-07-01), Morii et al.
patent: 5047519 (1991-09-01), Hobbs et al.
patent: 5093232 (1992-03-01), Urdea et al.
patent: 5171534 (1992-12-01), Smith et al.
patent: 5230781 (1993-07-01), Middendorf et al.
patent: 5241060 (1993-08-01), Engelhardt et al.
patent: 5260433 (1993-11-01), Engelhardt et al.
patent: 5270184 (1993-12-01), Walker et al.
patent: 5332666 (1994-07-01), Prober et al.
patent: 5346603 (1994-09-01), Middendorf et al.
patent: 5360523 (1994-11-01), Middendorf et al.
patent: 5439793 (1995-08-01), Rose et al.
patent: 5462584 (1995-10-01), Gavlin et al.
patent: 5462854 (1995-10-01), Coassin et al.
patent: 5470723 (1995-11-01), Walker et al.
patent: 5476928 (1995-12-01), Ward et al.
patent: 5503975 (1996-04-01), Smith et al.
patent: 5508178 (1996-04-01), Rose et al.
patent: 5563050 (1996-10-01), Peyman et al.
patent: 5569582 (1996-10-01), Tavernarakis et al.
patent: 5595891 (1997-01-01), Rose et al.
patent: 5612199 (1997-03-01), Western et al.
patent: 5639873 (1997-06-01), Barascult et al.
patent: 5665545 (1997-09-01), Malek et al.
patent: 5683872 (1997-11-01), Rudert et al.
patent: 5714323 (1998-02-01), Ohshima et al.
patent: 5798276 (1998-08-01), Haugland et al.
patent: 6270967 (2001-08-01), Whitcombe et al.
patent: 6326145 (2001-12-01), Whitcombe et al.
patent: 6410278 (2002-06-01), Notomi
patent: 6764821 (2004-07-01), Rabbani et al.
patent: 6974670 (2005-12-01), Notomi
patent: 7001721 (2006-02-01), Whitcombe et al.
patent: 265429 (1987-09-01), None
patent: 0302308 (1993-11-01), None
patent: 0231495 (1999-06-01), None
patent: 2338301 (1999-12-01), None
patent: 2338302 (2000-08-01), None
patent: WO 9200989 (1992-01-01), None
patent: WO9502690 (1995-01-01), None
patent: WO9704131 (1997-02-01), None
patent: WO 9806732 (1998-02-01), None
patent: WO 9843991 (1998-10-01), None
Grein, T., et al., “3 Deaza and 7 Deazapurines: duplex stability of oligonucleotides containing modified adenine or guanine bases,”Bioorganic&Medicinal Chemistry Letters4:971-976 (1994).
Sagi, J., et al., “Base-modified oligodeoxynucleotides. I. effect of 5-alkyl, 5-(1-alkenyl) and 5-(1-alkynyl) substitution of the pyrmidines on duplex stability and hydrophobicity,”Tetrahedron Letters34:2191-2194 (1993).
Sanghvi, Y.S., “Heterocyclic Base Modifications in Nucleic Acids and their Applications in Antisense Oligonucleotides,” Chapter 15 (pp. 273-288) ofAntisense Research and Applications, CRC Press, UK (1993).
Sowers, L.C., et al., “Equilibrium between a Wobble and Ionized Base Pair Formed between Fluorouracil and Guanine in DNA as Studied by Proton and Fluorine NMR,”J. Bio. Chem. 263:14794-14801 (1988).
Whitcombe, D. et al.,Nature Biotechnology17:804-807 (1999).
Wilton, S.D. et al., “Snapback SSCP Analysis: Engineered Conformation Changes for the Rapid Typing of Known Mutations,”Human Mutation11:252-258 (1998).
Patel, R. et al., “Formation of chimeric DNA primer extension products by template switching onto an annealed downstream oligonucleotide,”Proc. Natl. Acad. Sci.(USA) 93:2969-2974 (1996).
Walker, G.T et al., “Strand displacement amplification—an isothermal, in vitro DNA amplification technique,”Nucleic Acids Research20(7):1691-1696 (1992).
Kurfurst, R. et al., “Oligo-alpha-Deoxyribonucleotides with a Modified Nucleic Base and Covalently Linked to Reactive Agents,”Tetrahedron49(32):6975-6990 (1993).
Honeyman K. et al., “Development of a snapback method of single-stand conformation polymorphism analysis for geneotyping Golden Retrievers for the X-linked muscular dystrophy allele,”AJVR60(6):734-737 (1999).
Saiki, R.K. et al.,Science230:1350-1354 (1985).
Meyers, T.W. and Gelfand, D.H.,Biochemistry30(31):7661-7666 (1991).
Landegren U. et al.,Science241;1077 (1988).
Wu D. and Wallace, R.B.,Genomics4:560-569 (1989).
Barany F.,Proc. Natl. Acad. Sci.(USA) 88:189-193 (1991).
Kwoh D.Y. et al.,Proc. Natl. Acad. Sci.(USA) 86:1173-1177 (1989).
Kievits, T. et al.,Journal of Virological Methods35:273-286 (1991).
Walker, G.T. et al.,Proc. Natl. Acad. Sci.(USA) 89:392-396 (1992).
Saiki R.K. et al.,Science239:487-491 (1988).
Auer, T. et al.,Nucleic Acids Research24(24):5021-5025 (1996).
Maxam A. M. and Gilbert, W.,Proc. Natl. Acad. Sci.(USA) 74(2):560-564 (1977).
Sanger F., et al.,Proc. Natl. Acad. Sci.(USA) 74(12):5463-5467 (1977).
Beck S., et al.,Nucleic Acids Research17(13):5115-5123 (1989).
Ansorge W., et al.,Journal of Biochemical and Biophysical Methods13:315-323 (1986).
Sequenase Images™ Protocol Book , United States Biochemical Corporation, Cleveland, Ohio, pp. 106-107 (1993).
Beck S.,Methods in Enzymology184:612-617 (1990).
Wetmur J.G.,Critical Reviews in Biochemistry and Molecular Biology26(3/4):227-259 (1991).
Kornberg A. and Baker T.A.,DNA Replication, 2ndEdition, W.H. Freeman and Co., New York, New York, pp. 44-46 (1992).
Adams, R.L.P. et al.,The Biochemistry of the Nucleic Acids, Chapman & Hall, London, U.K., p. 31 (1992).
Prober J.M., et al.,Science238:336-341 (1987).
Kornberg A. and Baker T.A.,DNA Replication, 2ndEdition, W.H. Freeman and Co., New York, New York, pp. 447-449 (1992).
Zuker 2003 “Mfold web server for nucleic acid folding and hybridization prediction” Nucleic Acids Res. 31:3406-3415.
Auer et al. 1996 “Selective Amplification of RNA utilizing the nucleotide analog dITP ande Thermus thermophilus DNA polymerase” Nucleic Acids Res. 24:5021-5025.
Lodmell et al. 1995 “Genetic and Comparative Analyses Reveal an Alternative Secondary Structure in the Region of nt 912 inEscherichia coli16S RNA” Proc. Nat'l. Acad. Sci. US 92:10555-10559.
Pollack et al. 1993 “An RNA Stem-Loop Structure Directs Hepatitis B Virus Genomic RNA Encapsidation” J. Virol. 67:3254-3263.
Walker et al. 1992 “Isothermal in vitro Amplification of DNA by a Restriction Enzyme/DNA Polymerase System” Proc. Nat'l. Acad. Sci. USA 89:392-396.
Kievits et al. 1991 “NASBA (TM) Isothermal Enzymatic in vitro Nucleic Acid Amplifiaction Optimized for the Diagnosis of HIV-1 Infection” J. Virological Methods 35:273-286.
Beck 1990 “Colorimetric-detected DNA Sequencing” Meth Enzymol 184:612-617.
Blanco et al. 1989 “Highly Efficient DNA Synthesis by the phage ø29 DNA Polymerase: Symmetrical Mode of DNA Replication” J. Biol. chem. 264:8935-8940.
Beck et al. 1989 “Chemiluminescent detection of DNA: Application for NDA sequencing and hyb
Coleman Jack
Donegan James J.
Rabbani Elazar
Stavrianopoulos Jannis G.
Walner Marleen
Bogdanos, Esq. Natalie
Enzo Life Sciences, Inc.
Fedus, Esq. Ronald C.
Horlick Kenneth R.
Thomas David C
LandOfFree
Post-termination labeling of nucleic acid fragments and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Post-termination labeling of nucleic acid fragments and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Post-termination labeling of nucleic acid fragments and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4077002